Question 1

What is the catalog number for Lifastuzumab (Anti-SLC34A2)?

Accepted Answer

The catalog number for Lifastuzumab (Anti-SLC34A2) is A2350-1mg*25.

Question 2

What sizes are available for Lifastuzumab (Anti-SLC34A2)?

Accepted Answer

Lifastuzumab (Anti-SLC34A2) is available in the following size(s): 25x 1 mg.

Question 3

Is Lifastuzumab (Anti-SLC34A2) in stock?

Accepted Answer

Lifastuzumab (Anti-SLC34A2) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures Lifastuzumab (Anti-SLC34A2)?

Accepted Answer

Lifastuzumab (Anti-SLC34A2) is manufactured by Bimake.

Question 5

What is the estimated delivery time for Lifastuzumab (Anti-SLC34A2)?

Accepted Answer

Estimated delivery time for Lifastuzumab (Anti-SLC34A2) is approximately 15 business day(s), depending on your location.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 8

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Lifastuzumab (Anti-SLC34A2)

Product Specifications

CAS Number

Target

Applications

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD20 (B9E9), CF568 conjugate, 0.1mg/mL

CD46 (122.2), CF740 conjugate, 0.1mg/mL

CD86 (BU63), CF640R conjugate, 0.1mg/mL

CD5 (Cris-1), CF640R conjugate, 0.1mg/mL

CD54 / ICAM-1 (15.2), CF640R conjugate, 0.1mg/mL

BMI1 (Oncogene and Stem Cell Marker) (BMI1/2823), CF640R conjugate, 0.1mg/mL